Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 376–390 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5511 FBXO7 Gene PARK15 Parkinson Genetic Test This diagnostic test evaluates the FBXO7 gene for pathogenic variants associated with autosomal recessive juvenile-onset parkinsonism (PARK15). It utilizes Next-Generation Sequenci...	Whole Blood (3-5 mL EDTA), Extracted DNA (≥1 μg at ≥50 ng/μL), or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FBXO7 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)", "Copy Number Variations (CNVs)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% via ISO-Accredited NGS Processing"}, {"name": "Analytical Sensitivity", "reference_range": ">99.5% for SNVs, indels, CNVs at minimum 100× read depth"}, {"name": "Methodology", "reference_range": "NGS (Next-Generation Sequencing) with CNV Analysis"}] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Patients presenting with early-onset parkinsonism", "Differential diagnosis of early-onset movement disorders", "Family history suggestive of autosomal recessive parkinsonism"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G20 Clinical summary This diagnostic test evaluates the FBXO7 gene for pathogenic variants associated with autosomal recessive juvenile-onset parkinsonism (PARK15). It utilizes Next-Generation Sequencing (NGS) to detect single nucleotide variants, small insertions/deletions, and copy number variations.
TEST-4799 FCGR2B Gene Malaria Resistance Test This test evaluates genetic variants within the FCGR2B gene associated with innate resistance to severe malaria.	Peripheral blood (venous or FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FCGR2B gene variants", "Innate susceptibility to severe malaria"] Parameters [] Preparation [] Indications ["Individuals with a family history of malaria infections", "Personalized risk assessment for malaria susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 88825-8 ICD-10: Z13.89 Clinical summary This test evaluates genetic variants within the FCGR2B gene associated with innate resistance to severe malaria.
TEST-1115 Fecal Elastase‑1 Test This diagnostic test evaluates the level of pancreatic elastase-1 in a stool sample to assess exocrine pancreatic function.	Stool	Next business day (sample collected Tue/Fri by 6 PM, report before 4 PM next day)	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pancreatic Elastase-1 enzyme levels", "Exocrine pancreatic function"] Parameters [{"name": "Fecal Elastase-1", "reference_range": ">200 µg/g stool (Normal), 100-200 µg/g (Mild/Moderate Insufficiency), Preparation ["No special preparation or medication suspension is required.", "Continue pancreatic enzyme replacement therapy (e.g., Creon) as prescribed.", "Do not stop insulin or diabetes medications without a physician’s order."] Indications ["Suspected exocrine pancreatic insufficiency (EPI)", "Chronic pancreatitis", "Cystic fibrosis", "Unexplained steatorrhea", "Monitoring pancreatic function"] Measurement technique Confirm with laboratory Codes LOINC: 19123-9 ICD-10: K86.9, K86.1 Clinical summary This diagnostic test evaluates the level of pancreatic elastase-1 in a stool sample to assess exocrine pancreatic function.
TEST-1109 Felbamate Test This diagnostic test quantifies serum felbamate levels to guide therapeutic drug monitoring in epilepsy patients.	Serum	2–3 weeks (batch processing)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Felbamate Concentration"] Parameters [{"name": "Felbamate", "reference_range": "30–100 µg/mL"}] Preparation ["Collect serum 1 hour before the next dose", "Use a plain red-top tube without gel separator", "Send Out Consent Form (Form 35) is mandatory"] Indications ["Therapeutic drug monitoring for felbamate", "Assessing drug efficacy", "Monitoring for potential toxicity"] Measurement technique Confirm with laboratory Codes LOINC: 3586-2 ICD-10: Z79.899 Clinical summary This diagnostic test quantifies serum felbamate levels to guide therapeutic drug monitoring in epilepsy patients.
TEST-1696 Female Hypogonadism Panel Test This diagnostic test evaluates key hormones related to ovarian and pituitary function to help classify the type of female hypogonadism.	Serum	3 working days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FSH (Follicle-Stimulating Hormone)", "LH (Luteinizing Hormone)", "Estradiol", "AMH (Anti-Müllerian Hormone)", "Prolactin", "TSH (Thyroid-Stimulating Hormone)"] Parameters [{"name": "FSH", "reference_range": null}, {"name": "LH", "reference_range": null}, {"name": "Estradiol", "reference_range": null}, {"name": "AMH", "reference_range": null}, {"name": "Prolactin", "reference_range": null}, {"name": "TSH", "reference_range": null}] Preparation ["Fast for 8 hours (water allowed).", "Avoid biotin supplements for 48 hours prior.", "Schedule collection on Day 2 or 3 of the menstrual cycle (morning)."] Indications ["Evaluation of primary ovarian insufficiency", "Investigation of secondary amenorrhea", "Assessment of infertility", "Diagnosis of pituitary disorders affecting ovarian function"] Measurement technique Confirm with laboratory Codes LOINC: 101448-9 ICD-10: E28.3 Clinical summary This diagnostic test evaluates key hormones related to ovarian and pituitary function to help classify the type of female hypogonadism.
TEST-4830 FERMT3 Gene Leukocyte Adhesion Deficiency Type 3 (LAD3) Genetic Test This genetic test identifies pathogenic variants in the FERMT3 gene, confirming a diagnosis of Leukocyte Adhesion Deficiency Type 3 (LAD3).	Whole blood (EDTA), extracted DNA, or one drop blood on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FERMT3 gene", "Copy Number Variations (CNVs) in FERMT3"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "Mandatory clinical history review and genetic counselling session before sample collection"] Indications ["Suspected Leukocyte Adhesion Deficiency Type 3", "Family history of LAD3", "Recurrent severe infections with bleeding"] Measurement technique Confirm with laboratory Codes LOINC: 49863-9 ICD-10: D72.0 Clinical summary This genetic test identifies pathogenic variants in the FERMT3 gene, confirming a diagnosis of Leukocyte Adhesion Deficiency Type 3 (LAD3).
TEST-2717 FGF8 Gene Hypogonadotropic Hypogonadism Type 6 Genetic Test This test detects pathogenic variants in the FGF8 gene associated with autosomal dominant hypogonadotropic hypogonadism type 6.	Peripheral Whole Blood (3-5 mL in EDTA) or Extracted Genomic DNA (minimum 500 ng)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGF8 gene sequence", "Pathogenic variants in FGF8"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory", "Provide a detailed three-generation family pedigree"] Indications ["Suspected hypogonadotropic hypogonadism type 6", "Family history of hypogonadotropic hypogonadism", "Need for genetic confirmation for treatment planning"] Measurement technique Confirm with laboratory Codes LOINC: 21674-5 ICD-10: E23.0 Clinical summary This test detects pathogenic variants in the FGF8 gene associated with autosomal dominant hypogonadotropic hypogonadism type 6.
TEST-2215 FGFR1 Gene Trigonocephaly Type 1 Genetic Test This test analyzes the FGFR1 gene for pathogenic variants associated with trigonocephaly type 1 and related craniosynostosis syndromes.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR1 gene", "Single-nucleotide variants", "Small indels"] Parameters [] Preparation ["Provide detailed clinical history", "Provide three-generation family pedigree", "Attend mandatory genetic counselling session"] Indications ["Diagnosis of trigonocephaly type 1", "Diagnosis of related craniosynostosis syndromes", "Familial genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 51969-6 ICD-10: Q75.0, Q87.0, Z13.71 Clinical summary This test analyzes the FGFR1 gene for pathogenic variants associated with trigonocephaly type 1 and related craniosynostosis syndromes.
TEST-2897 FGFR2 Gene (Crouzon Syndrome) Genetic Test This test evaluates the FGFR2 gene for pathogenic variants associated with Crouzon syndrome.	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR2 gene", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Definitive diagnosis of Crouzon syndrome", "Differential exclusion of other craniosynostosis syndromes", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 93296-0 ICD-10: Q87.0 Clinical summary This test evaluates the FGFR2 gene for pathogenic variants associated with Crouzon syndrome.
TEST-2701 FGFR2 Gene Analysis for Jackson-Weiss Syndrome (Genetic Test) This test identifies pathogenic variants within the FGFR2 gene associated with Jackson-Weiss syndrome.	Peripheral Whole Blood or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in FGFR2 gene", "Coding exons and flanking splice regions"] Parameters [] Preparation ["No fasting required", "No medication changes needed for blood draw"] Indications ["Suspected Jackson-Weiss syndrome", "Family history of craniosynostosis-syndactyly disorders", "Need for genetic confirmation for surgical planning", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 91576-0 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants within the FGFR2 gene associated with Jackson-Weiss syndrome.
TEST-3077 FGFR2 Gene Apert Syndrome Genetic Test This test identifies pathogenic and likely pathogenic variants in the FGFR2 gene to confirm a diagnosis of Apert syndrome and related craniosynostosis disorders.	Peripheral whole blood (EDTA tube, 3–5 mL), extracted DNA, or FTA card blood spot	3–4 weeks from sample receipt at laboratory	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR2 gene sequence variants", "FGFR2 gene copy number variations"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Apert syndrome", "Suspected Crouzon syndrome", "Suspected Pfeiffer syndrome", "Other FGFR2-related craniosynostosis disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-1 ICD-10: Q87.0 Clinical summary This test identifies pathogenic and likely pathogenic variants in the FGFR2 gene to confirm a diagnosis of Apert syndrome and related craniosynostosis disorders.
TEST-5316 FGFR2 Gene Beare‑Stevenson Cutis Gyrata Syndrome Genetic Test This genetic test identifies pathogenic variants in the FGFR2 gene associated with Beare‑Stevenson cutis gyrata syndrome.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR2 gene"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Inform the phlebotomist of any anticoagulant medications or bleeding disorders."] Indications ["Suspected Beare‑Stevenson cutis gyrata syndrome", "Differential diagnosis of FGFR‑related craniosynostosis syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 82757-6 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants in the FGFR2 gene associated with Beare‑Stevenson cutis gyrata syndrome.
TEST-5498 FGFR3 Gene Achondroplasia Genetic Test This test identifies pathogenic variants in the FGFR3 gene associated with achondroplasia.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR3 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No special preparation required", "Test performed on peripheral whole blood"] Indications ["Diagnosis of achondroplasia", "Family planning for individuals with achondroplasia", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92720-5 ICD-10: Q77.4 Clinical summary This test identifies pathogenic variants in the FGFR3 gene associated with achondroplasia.
TEST-5248 FGFR3 Gene Crouzon Syndrome with Acanthosis Nigricans Genetic Test This test identifies pathogenic variants in the FGFR3 gene associated with Crouzon syndrome with acanthosis nigricans.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR3 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required.", "No medication adjustments required.", "Hydrate well.", "Provide detailed personal/family medical history."] Indications ["Suspected Crouzon syndrome with acanthosis nigricans", "Definitive molecular diagnosis", "Informed clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.0, L83 Clinical summary This test identifies pathogenic variants in the FGFR3 gene associated with Crouzon syndrome with acanthosis nigricans.
TEST-4593 FGFRL1 Gene Radioulnar Synostosis Genetic Test This genetic test evaluates the FGFRL1 gene for pathogenic variants associated with radioulnar synostosis and related phenotypes.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in FGFRL1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation ["No specific fasting required", "Avoid acute febrile illness or active systemic infection before blood collection"] Indications ["Suspected radioulnar synostosis", "Diagnosis of related skeletal, dermatological, or immunological phenotypes", "Family history of FGFRL1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94222-3 ICD-10: Q74.0 Clinical summary This genetic test evaluates the FGFRL1 gene for pathogenic variants associated with radioulnar synostosis and related phenotypes.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories